Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Levetiracetam (750mg) Tablet
Therapeutic Category
Antiepileptic, Neurology
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*10
Price
₹203/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Lapcetam 750 Tablet is a potent antiepileptic medication formulated with Levetiracetam (750 mg), designed to effectively manage seizures in patients with epilepsy. It helps in controlling partial-onset seizures, generalized tonic-clonic seizures, and myoclonic seizures associated with juvenile myoclonic epilepsy. Levetiracetam acts on the synaptic vesicle protein 2A, modulating neurotransmitter release and stabilizing brain activity. This mechanism reduces the likelihood and frequency of abnormal electrical activity in the brain, thereby preventing seizures.
The medication can be used as monotherapy for newly diagnosed patients or as an adjunctive treatment for individuals requiring additional seizure control. It is well-suited for adults and children, offering flexibility and reliability in managing epilepsy. With minimal interactions with other drugs, Lapcetam 750 Tablet is considered safe and effective for long-term use.
Adherence to the prescribed dosage schedule can significantly improve seizure management, allowing patients to regain independence and lead a more fulfilling life. This formulation is particularly helpful for individuals needing higher doses to achieve optimal control over their condition.
Common side effects may include fatigue, dizziness, headache, somnolence, and irritability. Rarely, mood changes or allergic reactions may occur.
Lapcetam 750 Tablet is indicated for treating partial-onset seizures, generalized tonic-clonic seizures, and myoclonic seizures in epilepsy.
This medicine should only be used under the supervision of a healthcare professional. Abrupt discontinuation can lead to withdrawal seizures. Ensure adherence to the prescribed dosage, and promptly report any unusual side effects to your doctor.
Store in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep out of reach of children.
Composition : Levetiracetam (500mg) Tablet
Composition : Levetiracetam (250mg) Tablet
Composition : Levetiracetam (1000mg) Tablet
Composition : Pregabalin (300mg) Capsule
Composition : Levetiracetam (1500mg) Infusion
Composition : Levetiracetam (1000mg) Infusion
Composition : Diclofenac (50mg) + Paracetamol (325mg) + Trypsin Chymotrypsin (50000AU)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Levetiracetam 750mg Tablet is an antiepileptic medicine used for the treatment and long-term management of epilepsy and seizure disorders. It is a strong neurology and chronic-care segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in neurology clinics, hospitals, and specialty healthcare centers. The 750mg strength is frequently prescribed for dose optimization and maintenance therapy, ensuring steady prescription demand and repeat business opportunities.
Yes, Cafoli Lifecare offers PCD pharma franchise opportunities for neurology and chronic-care formulations with monopoly rights, quality manufacturing standards, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from steady prescription demand, specialist neurologist recommendations, and long-term therapy requirements associated with epilepsy management when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this antiepileptic formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.